P

PTC Therapeutics
D

PTCT

47.860
USD
1.92
(4.18%)
مغلق
حجم التداول
0
الربح لكل سهم
8
العائد الربحي
-
P/E
7
حجم السوق
3,793,240,929
أصول ذات صلة
BMRN
BMRN
0.610
(1.06%)
58.110 USD
E
ESPR
0.03090
(3.92%)
0.81990 USD
INCY
INCY
1.070
(1.67%)
65.320 USD
NBIX
NBIX
2.560
(2.13%)
122.660 USD
Q
QURE
0.350
(2.31%)
15.510 USD
R
RARE
-0.560
(-1.57%)
35.120 USD
REGN
REGN
14.50
(2.46%)
603.11 USD
S
SRPT
0.430
(1.13%)
38.330 USD
VRTX
VRTX
10.22
(2.35%)
446.01 USD
المزيد
الأخبار المقالات

العنوان: PTC Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.